Joseph J Palamar1, Benjamin H Han2, Katherine M Keyes3. 1. New York University Grossman School of Medicine, Department of Population Health, 180 Madison Avenue, New York, NY 10016, United States; Center for Drug Use and HIV/HCV Research, New York University College of Global Public Health, 665 Broadway, New York, NY 10012, United States. Electronic address: joseph.palamar@nyulangone.org. 2. New York University Grossman School of Medicine, Department of Population Health, 180 Madison Avenue, New York, NY 10016, United States; Center for Drug Use and HIV/HCV Research, New York University College of Global Public Health, 665 Broadway, New York, NY 10012, United States; New York University Grossman School of Medicine, Department of Medicine, Division of Geriatric Medicine and Palliative Care, 550 First Avenue, BCD 615, New York, NY 10016, United States. 3. Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, United States.
Abstract
BACKGROUND: Prevalence of self-reported methamphetamine use has remained relatively stable over the past decade; however, deaths and seizures involving methamphetamine have been increasing. Research is needed to determine if select subgroups in the US are at increased risk for use. METHODS: We examined data from individuals ages ≥12 from the 2015-2018 National Survey on Drug Use and Health (n = 226,632), an annual nationally representative cross-sectional survey of non-institutionalized individuals in the US. Log-linear trends in past-year methamphetamine use were examined, stratified by demographic and drug use characteristics. RESULTS: Methamphetamine use increased in the US from 2015 to 2018, including among those reporting past-year use of ecstasy/MDMA (6.1 % to 10.8 % [p = .018], a 78.2 % increase), cocaine (8.4 % to 11.8 % [p = .013], a 40.1 % increase), and among those reporting past-year prescription opioid misuse (5.4 % to 8.0 % [p = .019], a 49.2 % increase). Increases were particularly pronounced among those reporting past-year use of heroin (22.5 % to 37.4 % [p = .032], a 66.2 % increase) and LSD (5.1 %-= to 10.3 % [p = .002], a 100.4 % increase). Small increases were also detected among heterosexuals (0.6 % to 0.7 % [p = .044], a 16.2 % increase), those with a high school diploma or less (1.0 % to 1.2 % [p = .020], a 22.0 % increase), and among those receiving government assistance (1.4 % to 1.8 % [p = .046], a 26.2 % increase). CONCLUSIONS: Methamphetamine use is increasing among people who use other drugs with sharp increases among people who use heroin or LSD in particular, and this could have serious public health consequences. Results may signal that methamphetamine use may continue to increase in the general population.
BACKGROUND: Prevalence of self-reported methamphetamine use has remained relatively stable over the past decade; however, deaths and seizures involving methamphetamine have been increasing. Research is needed to determine if select subgroups in the US are at increased risk for use. METHODS: We examined data from individuals ages ≥12 from the 2015-2018 National Survey on Drug Use and Health (n = 226,632), an annual nationally representative cross-sectional survey of non-institutionalized individuals in the US. Log-linear trends in past-year methamphetamine use were examined, stratified by demographic and drug use characteristics. RESULTS:Methamphetamine use increased in the US from 2015 to 2018, including among those reporting past-year use of ecstasy/MDMA (6.1 % to 10.8 % [p = .018], a 78.2 % increase), cocaine (8.4 % to 11.8 % [p = .013], a 40.1 % increase), and among those reporting past-year prescription opioid misuse (5.4 % to 8.0 % [p = .019], a 49.2 % increase). Increases were particularly pronounced among those reporting past-year use of heroin (22.5 % to 37.4 % [p = .032], a 66.2 % increase) and LSD (5.1 %-= to 10.3 % [p = .002], a 100.4 % increase). Small increases were also detected among heterosexuals (0.6 % to 0.7 % [p = .044], a 16.2 % increase), those with a high school diploma or less (1.0 % to 1.2 % [p = .020], a 22.0 % increase), and among those receiving government assistance (1.4 % to 1.8 % [p = .046], a 26.2 % increase). CONCLUSIONS:Methamphetamine use is increasing among people who use other drugs with sharp increases among people who use heroin or LSD in particular, and this could have serious public health consequences. Results may signal that methamphetamine use may continue to increase in the general population.
Authors: Joseph J Palamar; Alberto Salomone; Enrico Gerace; Daniele Di Corcia; Marco Vincenti; Charles M Cleland Journal: Int J Drug Policy Date: 2017-08-12
Authors: Janey Sewell; Valentina Cambiano; Andrew Speakman; Fiona C Lampe; Andrew Phillips; David Stuart; Richard Gilson; David Asboe; Nneka Nwokolo; Amanda Clarke; Alison J Rodger Journal: Int J Drug Policy Date: 2019-04-15
Authors: Sarah E Kidd; Jeremy A Grey; Elizabeth A Torrone; Hillard S Weinstock Journal: MMWR Morb Mortal Wkly Rep Date: 2019-02-15 Impact factor: 17.586
Authors: Steve Shoptaw; Michael J Li; Marjan Javanbakht; Amy Ragsdale; David Goodman-Meza; Pamina M Gorbach Journal: Drug Alcohol Depend Date: 2022-01-19 Impact factor: 4.492
Authors: Adam Viera; Jacob J van den Berg; Collette D Sosnowy; Nikita A Mehta; E Jennifer Edelman; Trace Kershaw; Philip A Chan Journal: AIDS Behav Date: 2022-03-18
Authors: Christopher M Jones; Debra Houry; Beth Han; Grant Baldwin; Alana Vivolo-Kantor; Wilson M Compton Journal: Ann N Y Acad Sci Date: 2021-09-24 Impact factor: 6.499
Authors: Justin C Strickland; William W Stoops; Kelly E Dunn; Kirsten E Smith; Jennifer R Havens Journal: Drug Alcohol Depend Date: 2021-05-21 Impact factor: 4.852
Authors: Manal Mansoor; Ryan McNeil; Taylor Fleming; Allison Barker; Sheila Vakharia; Kimberly Sue; Andrew Ivsins Journal: Int J Drug Policy Date: 2022-01-31
Authors: Adam Viera; Collette D Sosnowy; Jacob J van den Berg; Nikita A Mehta; E Jennifer Edelman; Trace Kershaw; Philip A Chan Journal: Subst Use Misuse Date: 2022-01-22 Impact factor: 2.362
Authors: Lara N Coughlin; Lewei Allison Lin; Mary Jannausch; Mark A Ilgen; Erin E Bonar Journal: Drug Alcohol Depend Date: 2021-07-28 Impact factor: 4.852
Authors: Jennifer R Havens; Hannah K Knudsen; Justin C Strickland; April M Young; Shanna Babalonis; Michelle R Lofwall; Sharon L Walsh Journal: Front Psychiatry Date: 2022-01-07 Impact factor: 4.157